title: A new short-term combination therapy of leprosy.
abstract: Report on the results with a new therapy with a complex combination (rifampicin + co-trimoxazole + isoniazid) for the treatment of leprosy. High tolerance. Duration of treatment 2 months.
authors.affiliation: Departamento de Lepra, Asunción, Paraguay.
authors.forename: E
authors.initials: E
authors.lastname: Freerksen
authors.forename: A E
authors.initials: AE
authors.lastname: Alvarenga
authors.forename: O
authors.initials: O
authors.lastname: Leguizamon
authors.forename: M V
authors.initials: MV
authors.lastname: de Morra
authors.forename: L A
authors.initials: LA
authors.lastname: Reyes
authors.forename: W
authors.initials: W
authors.lastname: von Ballestrem
mesh_terms: D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D004893:Erythema Nodosum / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use*; D007917:Leprostatic Agents / Q000627:therapeutic use*; D015439:Leprosy, Borderline / Q000188:drug therapy; D015440:Leprosy, Lepromatous / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D007917:Leprostatic Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D007538:Isoniazid; D012293:Rifampin